Industry map/Healthcare & Consumer Goods
Pharmaceuticals industry map
Who earns the money in Pharmaceuticals, and who keeps it. When a company spans several industries, only the relevant segment is counted.
FY2025 · 58 companies · ¥6.22T
Industry map
Companies ordered by revenue, connected by ownership (major shareholders). Arrows point from the shareholder to the investee.
- Industry size (revenue)
- ¥6.22T
- Companies
- 58
- Avg. salary（parent only）
- ¥8M
- Industry weather
- Sunny
YoY +5.1%
Avg. age 42.1
Operating income +17.3%
Asahi Kasei[3407]
Health Care
- Revenue
- ¥664.1B▲7.8%
- Operating income
- ¥83.5B▲30.3%
Margin 12.6%
Whole company: Revenue ¥3.07T · Net income ¥158.8B
Avg. salary ¥8.5M · 41.9（parent only）
- Teijin・Joint venture
Sumitomo Chemical[4005]
Sumitomo Pharma + 1 more
- Revenue
- ¥510.5B▲11.0%
- Operating income
- ¥111.3B▲183.1%
Margin 21.8%
Whole company: Revenue ¥2.33T · Net income ¥60.9B
Avg. salary ¥9.6M · 42.4（parent only）
Sumitomo Pharma[4506]
North America + 2 more
- Revenue
- ¥453.3B▲13.7%
- Operating income
- ¥97.5B▲25.2%
Margin 21.5%
Whole company: Revenue ¥453.3B · Net income ¥106.9B
Avg. salary ¥9.1M · 44.5（parent only）
- Sumitomo Chemical owns 51.8%
- Otsuka Holdings・Co-development
- Alfresa Holdings・Alliance
Kyowa Kirin[4151]
- Revenue
- ¥496.8B▲0.3%
- Operating income
- —
Avg. salary ¥9.9M · 42.4（parent only）
- Kirin Holdings owns 55.2%
Kirin Holdings[2503]
Pharmaceuticals
- Revenue
- ¥496.5B▲0.2%
- Operating income
- ¥102.3B▲11.4%
Margin 20.6%
Whole company: Revenue ¥2.43T · Net income ¥147.5B
Avg. salary ¥10M · 41.6（parent only）
Ajinomoto[2802]
Healthcare and others
- Revenue
- ¥341.5B▲4.0%
- Operating income
- —
Whole company: Revenue ¥1.58T · Net income ¥134.7B
Avg. salary ¥10.6M · 43.5（parent only）
Rohto Pharmaceutical[4527]
Japan + 1 more
- Revenue
- ¥294.7B▲11.1%
- Operating income
- ¥37.2B▲9.2%
Margin 12.6%
Whole company: Revenue ¥343.7B · Net income ¥34.2B
Avg. salary ¥8.5M · 42.1（parent only）
Towa Pharmaceutical[4553]
Domestic + 1 more
- Revenue
- ¥273.7B▲5.4%
- Operating income
- ¥27.6B▼0.4%
Margin 10.1%
Whole company: Revenue ¥273.7B · Net income ¥5.25B
Avg. salary ¥6.9M · 35.5（parent only）
Meiji Holdings[2269]
Pharmaceuticals
- Revenue
- ¥232.2B▲1.1%
- Operating income
- ¥30.5B▲23.1%
Margin 13.1%
Whole company: Revenue ¥1.17T · Net income ¥35.1B
Avg. salary ¥9.4M · 43.0（parent only）
Sawai Group Holdings[4887]
- Revenue
- ¥201.7B
- Operating income
- ¥15.9B
Margin 7.9%
Avg. salary ¥9.4M · 43.7（parent only）
Tsumura &[4540]
- Revenue
- ¥192.6B▲6.4%
- Operating income
- ¥35.2B▼12.2%
Margin 18.3%
Avg. salary ¥9.1M · 41.9（parent only）
Kobayashi Pharmaceutical[4967]
Domestic Business + 1 more
- Revenue
- ¥165.1B▼0.0%
- Operating income
- ¥14.8B▼39.7%
Margin 9.0%
Whole company: Revenue ¥165.7B · Net income ¥3.66B
Avg. salary ¥7.6M · 41.2（parent only）
※ Card revenue and operating income cover only the segment in this industry; “Whole company” shows consolidated revenue and net income.
Other companies: Teijin · Nitto Denko · KYORIN Pharmaceutical · Mochida Pharmaceutical · Qol Holdings · Zeria Pharmceutical · Kaneka · Nipro · Kissei Pharmaceutical · Kaken Pharmaceutial · Nippon Kayaku · ASKA Pharmaceutical Holdings · Fuso Pharmaceutical Industries · Toray Industries · Fuji Pharma · Daito Pharmaceutical · NOF · Denka · JCR Pharmaceuticals · Alfresa Holdings · Taiyo Holdings · Astena Holdings · Toyobo · Nippon Chemiphar · Yakult Honsha · Nichiban · Seikagaku · UBE · Osaka Soda · Suzuken · Katakura Industries · noevir holdings · Wakamoto Pharmaceutical · KOA Shoji Holdings · Sakai Chemical Industry · Taiko Pharmaceutical · Nissan Chemical · Morishita Jintan · Nihon Nohyaku · Meito …+6
The weather is derived mechanically from year-over-year totals of revenue and operating income (both up = sunny, both down = rainy).
Who earns the money
Area = revenue from businesses in this industry. Color = operating margin.
Who makes a profit
Across = revenue (log scale), up = operating margin, bubble size = operating income.
Ranking and momentum
| Rank | Company (business) | Revenue | Share | Op. margin | CAGR | FCF* |
|---|---|---|---|---|---|---|
| 1 | Asahi KaseiHealth Care | ¥664.1B | 10.7% | 12.6% | +12.4% | ¥92.1B |
| 2▲2 | Sumitomo ChemicalSumitomo Pharma + 1 more | ¥510.5B | 8.2% | 21.8% | — | — |
| 3▼1 | Kyowa Kirin | ¥496.8B | 8.0% | — | +9.0% | ¥13.1B |
| 4▼1 | Kirin HoldingsPharmaceuticals | ¥496.5B | 8.0% | 20.6% | +9.0% | ¥119.8B |
| 5 | Sumitomo PharmaNorth America + 2 more | ¥453.3B | 7.3% | 21.5% | — | ¥64.4B |
| 6 | AjinomotoHealthcare and others | ¥341.5B | 5.5% | — | +8.0% | ¥134.8B |
| 7 | Rohto PharmaceuticalJapan + 1 more | ¥294.7B | 4.7% | 12.6% | +13.5% | ¥21.5B |
| 8 | Towa PharmaceuticalDomestic + 1 more | ¥273.7B | 4.4% | 10.1% | +13.4% | ¥6.3B |
| 9 | Meiji HoldingsPharmaceuticals | ¥232.2B | 3.7% | 13.1% | +5.5% | -¥47.2B |
| 10new | Sawai Group Holdings | ¥201.7B | 3.2% | 7.9% | +1.0% | -¥17B |
| 11▼1 | Tsumura & | ¥192.6B | 3.1% | 18.3% | +10.4% | -¥9.66B |
| 12▼1 | Kobayashi PharmaceuticalDomestic Business + 1 more | ¥165.1B | 2.7% | 8.9% | +3.2% | ¥11.6B |
| 13▼1 | TeijinHelthcare | ¥138.6B | 2.2% | 9.7% | — | ¥38.7B |
| 14 | Nitto DenkoHuman life | ¥137.2B | 2.2% | -3.7% | +13.1% | ¥95.6B |
| 15▼2 | KYORIN Pharmaceutical | ¥126.3B | 2.0% | 2.8% | +4.6% | ¥2.4B |
| 16▼1 | Mochida Pharmaceutical | ¥117B | 1.9% | 8.7% | +1.5% | -¥10B |
| 17▲2 | Qol HoldingsPharmaceutical business | ¥99B | 1.6% | 7.0% | — | ¥10.6B |
| 18▼1 | Zeria PharmceuticalEthical drug business + 1 more | ¥89B | 1.4% | 20.8% | +10.7% | ¥7.06B |
| 19▲1 | KanekaHealth Care Solutions Unit | ¥83B | 1.3% | 17.9% | +8.9% | -¥3.26B |
| 20▼2 | NiproMedicine related | ¥81.1B | 1.3% | 14.9% | +2.2% | -¥7.63B |
| 21 | Kissei PharmaceuticalPharmaceutical products | ¥78B | 1.3% | -5.8% | +9.5% | -¥7.12B |
| 22▼6 | Kaken PharmaceutialMedicine | ¥74.3B | 1.2% | -3.1% | +0.2% | -¥16.5B |
| 23▼1 | Nippon KayakuLife Science Business Unit | ¥73B | 1.2% | 13.3% | — | ¥3.92B |
| 24▼1 | ASKA Pharmaceutical Holdingspharmaceutical business + 2 more | ¥70.9B | 1.1% | 10.7% | +5.9% | ¥3.43B |
| 25▼1 | Fuso Pharmaceutical Industries | ¥62.3B | 1.0% | 4.2% | +5.9% | -¥7.88B |
| 26▼1 | Toray IndustriesLife science | ¥52.4B | 0.8% | -0.2% | +0.2% | ¥65.3B |
| 27▲1 | Fuji Pharma | ¥51.7B | 0.8% | 9.7% | +11.0% | ¥1.95B |
| 28▼1 | Daito Pharmaceutical | ¥50.6B | 0.8% | 5.2% | +1.0% | -¥1.13B |
| 29▼3 | NOFPharmaceuticals, Medicals and Health | ¥49.9B | 0.8% | 31.7% | — | ¥21.5B |
| 30▼1 | DenkaLife Innovation | ¥40.5B | 0.7% | 15.4% | -3.2% | -¥31.5B |
| 31▲1 | JCR Pharmaceuticals | ¥40.3B | 0.6% | 1.4% | -5.7% | -¥11.7B |
| 32▼2 | Alfresa HoldingsManufacturing business | ¥37.2B | 0.6% | 3.2% | +1.8% | ¥10B |
| 33▲1 | Taiyo HoldingsMedical and pharmaceutical | ¥36.5B | 0.6% | 13.9% | +11.7% | ¥23B |
| 34▼1 | Astena HoldingsFine Chemicals + 1 more | ¥34.8B | 0.6% | 5.8% | -0.4% | ¥218M |
| 35▼4 | ToyoboLife Science | ¥34.5B | 0.6% | 0.2% | -0.4% | ¥15.9B |
| 36▼1 | Nippon ChemipharMedicine | ¥31.9B | 0.5% | 0.6% | +0.3% | -¥329M |
| 37▲1 | Yakult HonshaOther | ¥26B | 0.4% | 5.1% | +10.6% | -¥13.1B |
| 38▲1 | NichibanMedical business | ¥24.9B | 0.4% | 25.4% | +6.9% | ¥469M |
| 39▼2 | SeikagakuPharmaceutical | ¥24.5B | 0.4% | -6.7% | -1.2% | -¥7.37B |
| 40▼4 | UBEPharmaceutical | ¥20.6B | 0.3% | -6.1% | — | -¥12.5B |
| 41▲1 | Osaka SodaHealthcare | ¥14.6B | 0.2% | 48.9% | — | ¥12.5B |
| 42▲2 | SuzukenThe healthcare product development business | ¥11.9B | 0.2% | 7.0% | — | ¥15.7B |
| 43 | Katakura IndustriesPharmaceuticals business | ¥11.7B | 0.2% | 8.2% | -0.9% | ¥5.7B |
| 44▲1 | noevir holdingsMedicine and grocery | ¥11.5B | 0.2% | 8.5% | +0.9% | ¥5.41B |
| 45▲3 | Wakamoto PharmaceuticalEthical products business-related + 2 more | ¥9.71B | 0.2% | 1.9% | +4.3% | -¥1.1B |
| 46 | KOA Shoji HoldingsPharmaceutical Marketing Business | ¥8.67B | 0.1% | 24.6% | +5.4% | ¥1.89B |
| 47 | Sakai Chemical IndustryMedical business | ¥8.39B | 0.1% | -0.6% | — | ¥8.41B |
| 48▲2 | Taiko PharmaceuticalPharmaceuticals Business | ¥5.77B | 0.1% | 27.3% | +7.3% | ¥510M |
| 49 | Nissan ChemicalMedicines | ¥5.13B | 0.1% | 26.3% | -5.9% | ¥44.5B |
| 50▲1 | Morishita JintanConsumer business division | ¥4.72B | 0.1% | -2.1% | — | -¥77M |
Showing the top 50. See all 58 in the list below
* FCF is company-wide (not disclosed by segment). CAGR covers the available years, up to five.
How they make money differently
Where each company's ¥100 of sales goes, and how much it keeps (company-wide).
- Cost of sales
- Operating costs
- SG&A
- Other
- Operating profit
- Kyowa Kirin263341
- Sumitomo Pharma433624
- Tsumura &532918
- Nitto Denko621518
- Zeria Pharmceutical275914
- Ajinomoto8713
- Rohto Pharmaceutical444412
- Kirin Holdings52379
- Kobayashi Pharmaceutical49429
- Mochida Pharmaceutical52399
- Nippon Kayaku70219
- Asahi Kasei67258
- Towa Pharmaceutical64288
- Meiji Holdings69238
- Sawai Group Holdings711388
- ASKA Pharmaceutical Holdings52408
- Sumitomo Chemical71247
- Nipro6826
- Qol Holdings869
- Kaneka7224
- Fuso Pharmaceutical Industries7422
- KYORIN Pharmaceutical5938
- Kaken Pharmaceutial4853loss ¥1
- Kissei Pharmaceutical5350loss ¥3
- Teijin8127loss ¥8
Showing the 25 largest companies by revenue.
Ownership links
From the major-shareholder section of annual securities reports.
- Kirin HoldingsIn industry
- SubsidiaryKyowa Kirin55.2%
- Sumitomo ChemicalIn industry
- SubsidiarySumitomo Pharma51.8%
- 株式会社ＡＤＥＫＡOutside
- SubsidiaryNihon Nohyaku51.0%
- 株式会社メディパルホールディングスOutside
- AffiliateJCR Pharmaceuticals23.8%
- AffiliateQol Holdings20.2%
- ＤＩＣ株式会社Outside
- AffiliateTaiyo Holdings20.0%
- Rohto PharmaceuticalIn industry
- StakeWakamoto Pharmaceutical11.4%
- StakeMorishita Jintan8.6%
- Kissei PharmaceuticalIn industry
- StakeWakamoto Pharmaceutical10.9%
- StakeJCR Pharmaceuticals4.0%
- Takeda PharmaceuticalIn industry
- StakeASKA Pharmaceutical Holdings7.8%
- 三井物産株式会社Outside
- StakeKatakura Industries6.9%
- Zeria PharmceuticalIn industry
- StakeASKA Pharmaceutical Holdings6.6%
- StakeNippon Chemiphar3.3%
- 株式会社ソトーOutside
- StakeToabo6.2%
- Shionogi &In industry
- StakeToho Holdings5.4%
- 日本電気硝子株式会社Outside
- StakeNipro5.2%
- StakeKissei Pharmaceutical5.0%
- 株式会社フジ・メディア・ホールディングスOutside
- StakeYakult Honsha4.4%
- Daiichi SankyoIn industry
- StakeQol Holdings3.5%
- 大成建設株式会社Outside
- StakeKatakura Industries3.5%
- 株式会社ニッスイOutside
- StakeMochida Pharmaceutical3.4%
- 森永乳業株式会社Outside
- StakeZeria Pharmceutical3.3%
- 日邦産業株式会社Outside
- StakeMuromachi Chemicals3.3%
- 双日株式会社Outside
- StakeToabo3.1%
- Toray IndustriesIn industry
- StakeKaken Pharmaceutial3.0%
The company on each card is a major shareholder of the companies listed under it (latest 'major shareholders' disclosure). 50%+ is labelled subsidiary and 20%+ affiliate, based on ownership alone. Stakes under 3% are omitted.
Compare the leaders side by side
All companies in Pharmaceuticals (by revenue)
All 70 companies in this industry, ranked by revenue in each company's latest fiscal year. For companies that belong through one business segment, the figure is that segment's revenue.
- Takeda Pharmaceutical¥4.26T
- Otsuka Holdings¥2.02T
- Astellas Pharma¥1.6T
- Daiichi Sankyo¥1.6T
- Chugai Pharmaceutical¥1.11T
- Eisai¥741.8B · 7.2%
- Asahi Kasei¥664.1B · 12.6%
- Sumitomo Chemical¥510.5B · 21.8%
- ONO Pharmaceutical¥502.7B
- Kyowa Kirin¥496.8B
- Kirin Holdings¥496.5B · 20.6%
- Sumitomo Pharma¥453.3B · 21.5%
- Shionogi &¥410.1B
- Ajinomoto¥341.5B
- Santen Pharmaceutical¥302B
- Rohto Pharmaceutical¥294.7B · 12.6%
- Towa Pharmaceutical¥273.7B · 10.1%
- Meiji Holdings¥232.2B · 13.1%
- Sawai Group Holdings¥201.7B · 7.9%
- Tsumura &¥192.6B · 18.3%
- Kobayashi Pharmaceutical¥165.1B · 8.9%
- Nippon Shinyaku¥148.3B
- Teijin¥138.6B · 9.7%
- Nitto Denko¥137.2B · -3.7%
- KYORIN Pharmaceutical¥126.3B · 2.8%
- Mochida Pharmaceutical¥117B · 8.7%
- Qol Holdings¥99B · 7.0%
- Zeria Pharmceutical¥89B · 20.8%
- Kaneka¥83B · 17.9%
- Nipro¥81.1B · 14.9%
- Kissei Pharmaceutical¥78B · -5.8%
- Kaken Pharmaceutial¥74.3B · -3.1%
- Nippon Kayaku¥73B · 13.3%
- ASKA Pharmaceutical Holdings¥70.9B · 10.7%
- Fuso Pharmaceutical Industries¥62.3B · 4.2%
- Toray Industries¥52.4B · -0.2%
- Fuji Pharma¥51.7B · 9.7%
- Daito Pharmaceutical¥50.6B · 7.2%
- NOF¥49.9B · 31.7%
- Denka¥40.5B · 15.4%
- JCR Pharmaceuticals¥40.3B · 1.4%
- Alfresa Holdings¥37.2B · 3.2%
- Taiyo Holdings¥36.5B · 13.9%
- Astena Holdings¥34.8B · 5.8%
- Toyobo¥34.5B · 0.2%
- Nippon Chemiphar¥31.9B · 0.6%
- Yakult Honsha¥26B · 5.1%
- Nichiban¥24.9B · 25.4%
- Seikagaku¥24.5B · -6.7%
- UBE¥20.6B · -6.1%
- GNI Group¥18.3B · 2.0%
- PeptiDream¥15.4B · 1.6%
- Osaka Soda¥14.6B · 48.9%
- Suzuken¥11.9B · 7.0%
- Katakura Industries¥11.7B · 8.2%
- noevir holdings¥11.5B · 8.5%
- Wakamoto Pharmaceutical¥9.71B · 1.9%
- KOA Shoji Holdings¥8.96B · 23.7%
- Sakai Chemical Industry¥8.39B · -0.6%
- Taiko Pharmaceutical¥5.77B · 27.3%
- Nissan Chemical¥5.13B · 26.3%
- Morishita Jintan¥4.72B · -2.1%
- Nihon Nohyaku¥4.17B · 18.4%
- Muromachi Chemicals¥3.99B · 15.9%
- Meito¥3.55B · 22.8%
- Toho Holdings¥2.65B · 10.6%
- AFC-HD AMS Life Science¥2.47B · 9.3%
- TOC¥2.03B · 0.6%
- SymBio Pharmaceuticals¥1.31B · -339.6%
- Toabo¥803M · -7.5%
Revenue · Op. margin
Related industries
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.